Issues in biosecurity and biosafety.

23:56 EDT 21st August 2014 | BioPortfolio

Summary of "Issues in biosecurity and biosafety."

The role of non-governmental organisations and other interested observers - civil society - has long been neglected by governments in the quest for a world secure from the threat of biological weapons or bioterrorism. New trends illustrate a greater appreciation of a strong need for a cooperative partnership. Governments need to accept and embrace some of these new trends and new technologies. At least since 2001 and the Amerithrax anthrax letters, the USA has had a significant focus on biosecurity and the related subject of biosafety. Biosecurity has also been raised to a place of prominence in security discussions throughout much of the rest of the globe, largely through the mechanisms of the Biological and Toxin Weapons Convention and related groups, but also through the World Health Organization and the implementation of the International Health Regulations, which is scheduled for 2012. Despite this attention, a clear understanding of the meanings of biosecurity and biosafety has yet to be achieved. Partly because of this lack of definition, and largely because of a broader understanding of the capabilities of the life sciences, many topics have begun to fall under the heading of biosecurity. This paper will not be able to explore all of these new topics but will instead attempt to present an overview of some of the issues at play today in the biosecurity dialogue.

Affiliation

Office of Biological Weapons Affairs, Bureau of Verification, Compliance and Implementation, US Department of State, 2201 C Street NW, Room 5669, Washington, DC 20520, USA.

Journal Details

This article was published in the following journal.

Name: International journal of antimicrobial agents
ISSN: 1872-7913
Pages:

Links

PubMed Articles [2563 Associated PubMed Articles listed on BioPortfolio]

Ebola in West Africa: A Familiar Pattern?

Medicine for Policymakers is a Journal column that provides decision makers with brief explanations of the meaning and implications for biosecurity of clinical issues. The articles describe, for a non...

Evaluation of the level of knowledge and compliance with standart precautions and the safety standard (NR-32) amongst physicians from a public university hospital, Brazil.

Brazil is the first country in the world to have broad coverage standard (NR-32) focused on protecting health workers exposed to biological risks. This study evaluated the degree of knowledge of the N...

Environmental Risk Assessment of Clinical Trials Involving Modified Vaccinia Virus Ankara (MVA)-Based Vectors.

The modified vaccinia virus Ankara (MVA) strain, which has been developed as a vaccine against smallpox, is since the nineties widely tested in clinical trials as recombinant vector for vaccination or...

Economic risk analysis model for bovine viral diarrhea virus biosecurity in cow-calf herds.

A stochastic model was designed to calculate the cost-effectiveness of biosecurity strategies for bovine viral diarrhea virus (BVDV) in cow-calf herds. Possible sources of BVDV introduction considered...

Applying Bayesian network modelling to understand the links between on-farm biosecurity practice during the 2007 equine influenza outbreak and horse managers' perceptions of a subsequent outbreak.

Australia experienced its first ever outbreak of equine influenza in August 2007. Horses on 9359 premises were infected over a period of 5 months before the disease was successfully eradicated through...

Clinical Trials [215 Associated Clinical Trials listed on BioPortfolio]

Avian Influenza Studies In Lebanon

The highly pathogenic avian influenza (HPAI) H5N1 virus arrived in the Middle East in 2005 and has since established itself in local domestic birds and is now considered endemic in several...

Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy

Rationale: At present, virtually no evidence exists regarding mid to long-term patient-reported health outcomes (e.g., health related quality of life-HRQOL) of CML patients treated with Im...

Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function

The purpose of this study is to ask youn women diagnosed with ovarian cancer who have undergone surgery that will allow them to have children in the future, on issues such as: education ab...

Social-Psychological Aspects of Orbital Exenteration

Primary Objectives: - To characterize the physical adaptation and social-psychological issues of cancer patients who survive and suffer from changes in their normal facial appeara...

Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron)

The treatment of multiple sclerosis was evolving in light of specific drug therapies to treat the disease, refinements and acceptance of imaging with MRI to diagnose and monitor the diseas...

Medical and Biotech [MESH] Definitions

Clusters of topics that fall within the domain of BIOETHICS, the field of study concerned with value questions that arise in biomedicine and health care delivery.

The portion of an interactive computer program that issues messages to and receives commands from a user.

A method of data collection and a qualitative research tool in which a small group of individuals are brought together and allowed to interact in a discussion of their opinions about topics, issues, or questions.

The act or practice of killing for reasons of mercy, i.e., in order to release a person or animal from incurable disease, intolerable suffering, or undignified death. (from Beauchamp and Walters, Contemporary Issues in Bioethics, 5th ed)

The commission charged with evaluating issues and factors which affect the implementation of the PROSPECTIVE PAYMENT SYSTEM.

Search BioPortfolio: